| 11584742 |
Substituted aminothiazoles as inhibitors of nucleases |
Benoit Carbain, Stepan Havel, Jiri Damborsky, Jan Brezovsky, Lukas Daniel +3 more |
2023-02-21 |
|
| 11498920 |
4-(1H-imidazol-5-yl)-1H-pyrrolo[2, 3-b] pyridines for use in the treatment of leukaemias, lymphomas and solid tumors |
Vitezslav Bryja, Pavlina Janovska, Michaela Gregorova, Vaclav Nemec, Prashant Khirsariya |
2022-11-15 |
|
| 11453663 |
Substituted propanamides as inhibitors of nucleases |
Benoit Carbain, Stepan Havel, Vit Vsiansky, Fedor Nikulenkov, Lumir Krejci |
2022-09-27 |
|
| 9969741 |
Pyrazolotriazines as inhibitors of nucleases |
Jiri Damborsky, Fedor Nikulenkov, Alexandra Sisakova, Stepan Havel, Lumir Krejci +3 more |
2018-05-15 |
|
| 9902733 |
Furopyridines as inhibitors of protein kinases |
Michaela Petrujova, Vaclav Nemec |
2018-02-27 |
|
| 8673924 |
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors |
Timothy J. Guzi, Michael P. Dwyer, Ronald J. Doll, Viyyoor M. Girijavallabhan, Alan K. Mallams +15 more |
2014-03-18 |
$46,244,000 |
| 8603998 |
Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors |
Timothy J. Guzi, David A. Parry, Marc A. Labroli, Michael D. Dwyer |
2013-12-10 |
$69,974,000 |
| 8586576 |
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors |
Timothy J. Guzi, Michael P. Dwyer, Marc A. Labroli, Kartik M. Keertikar |
2013-11-19 |
$50,784,000 |
| 8580782 |
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors |
Timothy J. Guzi, Michael P. Dwyer, Marc A. Labroli, Kartik M. Keertikar |
2013-11-12 |
$66,896,000 |
| 8211854 |
Methods for inhibiting protein kinases |
Timothy J. Guzi, Michael P. Dwyer, David A. Parry |
2012-07-03 |
|
| 7807683 |
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors |
Timothy J. Guzi, Michael P. Dwyer, Ronald J. Doll, Viyyoor M. Girijavallabhan, Alan K. Mallams +13 more |
2010-10-05 |
|
| 7776865 |
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors |
Timothy J. Guzi, Michael P. Dwyer, Carmen Alvarez |
2010-08-17 |
|
| 7700773 |
4-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo[1,5-a]pyridines, pyrazolo[1,5-c]pyrimidines and 2H-indazole compounds and 5-cyano, 5-amino, and 5-aminomethyl derivatives of imidazo[1,2-a]pyridines, and imidazo[1,5-a]pyrazines as cyclin dependent kinase inhibitors |
Alan K. Mallams, Vincent S. Madison |
2010-04-20 |
|
| 7645762 |
Substituted pyrazolo[1,5-a] pyrimidines as protein kinase inhibitors |
Timothy J. Guzi, Michael P. Dwyer |
2010-01-12 |
|
| 7642266 |
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors |
Timothy J. Guzi, Michael P. Dwyer |
2010-01-05 |
|
| 7605155 |
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors |
Timothy J. Guzi, Michael P. Dwyer, Marc A. Labroli, Kartik M. Keertikar |
2009-10-20 |
$142,962,000 |
| 7601724 |
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors |
Timothy J. Guzi, Michael P. Dwyer |
2009-10-13 |
$143,977,000 |
| 7576085 |
Imidazopyrazines as cyclin dependent kinase inhibitors |
Timothy J. Guzi, Michael P. Dwyer, Lianyun Zhao, Patrick J. Curran, David B. Belanger +3 more |
2009-08-18 |
$205,277,000 |
| 7563798 |
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors |
Timothy J. Guzi, Michael P. Dwyer, M. Arshad Siddiqui, Panduranga Adulla P. Reddy, David B. Belanger +2 more |
2009-07-21 |
$215,854,000 |
| 7557104 |
Imidazopyrazines as protein kinase inhibitors |
Lianyun Zhao, Panduranga Adulla P. Reddy, Neng-Yang Shih, Timothy J. Guzi, M. Arshad Siddiqui |
2009-07-07 |
$211,246,000 |
| 7514442 |
Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors |
Timothy J. Guzi, Michael P. Dwyer, Ronald J. Doll, Viyyoor M. Girijavallabhan, Carmen Alvarez +9 more |
2009-04-07 |
$400,372,000 |
| 7511049 |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
Timothy J. Guzi, Michael P. Dwyer, Ronald J. Doll, Viyyoor M. Girijavallabhan, Lawrence Wayne Dillard +4 more |
2009-03-31 |
$75,956,000 |
| 7476681 |
17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
Timothy J. Guzi |
2009-01-13 |
$371,128,000 |
| 7470695 |
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors |
Timothy J. Guzi, Michael P. Dwyer, Ronald J. Doll, Viyyoor M. Girijavallabhan, Lawrence Wayne Dillard +4 more |
2008-12-30 |
$324,492,000 |
| 7468372 |
Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors |
Timothy J. Guzi, Michael P. Dwyer, Ronald J. Doll, Viyyoor M. Girijavallabhan, Chad Knutson +6 more |
2008-12-23 |
$329,278,000 |
